Search alternatives:
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
non decrease » nn decrease (Expand Search), note decreased (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
e non » _ non (Expand Search), a non (Expand Search), i non (Expand Search)
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
non decrease » nn decrease (Expand Search), note decreased (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
e non » _ non (Expand Search), a non (Expand Search), i non (Expand Search)
-
8201
-
8202
-
8203
Individual data 2020.
Published 2024“…Similarly, pNS incidence per 100,000 person-years decreased from 151.7 (95% CI: 112.7–203.4) to 27.0 (95% CI: 12.5–55.5). …”
-
8204
Household data 2022.
Published 2024“…Similarly, pNS incidence per 100,000 person-years decreased from 151.7 (95% CI: 112.7–203.4) to 27.0 (95% CI: 12.5–55.5). …”
-
8205
Persons with epilepsy data 2022.
Published 2024“…Similarly, pNS incidence per 100,000 person-years decreased from 151.7 (95% CI: 112.7–203.4) to 27.0 (95% CI: 12.5–55.5). …”
-
8206
Ivermectin coverage in 2019 and 2021.
Published 2024“…Similarly, pNS incidence per 100,000 person-years decreased from 151.7 (95% CI: 112.7–203.4) to 27.0 (95% CI: 12.5–55.5). …”
-
8207
Individual data 2022.
Published 2024“…Similarly, pNS incidence per 100,000 person-years decreased from 151.7 (95% CI: 112.7–203.4) to 27.0 (95% CI: 12.5–55.5). …”
-
8208
Household data 2020.
Published 2024“…Similarly, pNS incidence per 100,000 person-years decreased from 151.7 (95% CI: 112.7–203.4) to 27.0 (95% CI: 12.5–55.5). …”
-
8209
Persons with epilepsy data 2020.
Published 2024“…Similarly, pNS incidence per 100,000 person-years decreased from 151.7 (95% CI: 112.7–203.4) to 27.0 (95% CI: 12.5–55.5). …”
-
8210
-
8211
-
8212
-
8213
Selective Synthesis, Isolation, and Crystallographic Characterization of LaSc<sub>2</sub>N@<i>I</i><sub><i>h</i></sub>‑C<sub>80</sub>
Published 2012“…Results from chemically adjusting plasma temperature, energy, and reactivity (CAPTEAR) experiments indicate that a 10 wt % addition of Cu(NO<sub>3</sub>)<sub>2</sub>·2.5H<sub>2</sub>O to a mixture of La<sub>2</sub>O<sub>3</sub> and Sc<sub>2</sub>O<sub>3</sub> decreases the amount of C<sub>60</sub> and C<sub>70</sub> found in soot extracts by an order of magnitude. …”
-
8214
Scree plot curve for five sets of models for the upper auricle.
Published 2024“…<p>PC, principal component; EV, eigen values. The EVs rapidly decrease until PC5 for the sets with 123, 242, and 300 models (arrow a) and PC6 for the sets with 363 and 414 models (arrow b).…”
-
8215
-
8216
Ocean acidification at a coastal CO<sub>2</sub> vent induces expression of stress-related transcripts and transposable elements in the sea anemone <i>Anemonia viridis</i>
Published 2019“…The diversity of reef-building organisms decreases as seawater CO<sub>2</sub> increases along natural gradients, yet soft-bodied animals, such as sea anemones, are often resilient. …”
-
8217
Macrocyclic Metalloenediynes of Cu(II) and Zn(II): A Thermal Reactivity Comparison
Published 2001“…Specifically, as the size of the macrocycle increases, the temperatures at which these compounds undergo Bergman cyclization decrease by ∼5 °C per additional carbon atom, leading to an overall decrease across the series of 19 °C. …”
-
8218
Long-term sucrose intake (12 weeks) increases α4(nonα6)β2* nAChR and decreases α6β2* nAChR levels in rat nucleus accumbens (NAc).
Published 2016“…<p>Quantitative analyses of α4(nonα6)β2* nAChR binding using <sup>125</sup>I-Epibatidine binding in the absence and presence of α-CtxMII show show a significant increase in α4(nonα6)β2* nAChRs (A and B) with a decrease in α6β2* nAChRs (C and D) after short-term (4 week) and long-term (12 week) sucrose exposure in the intermittent-access two-bottle choice paradigm. …”
-
8219
-
8220